Details for 2012782600

Up to date per 03.04.2026

Actions

Title / Product Name

KRISTALLINE SALZE VON (4S,4AS,5AR,12AS-)4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACEN-2-CARBONSÄUREAMID UND VERFAHREN ZU IHRER VERWENDUNG

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2012782600

EP Publication Number

2707003

E-Number

1126005

Language

PCT Number

US12037838

Publication Date

19.03.2014 A

01.05.2019 B1

Registration Date

01.05.2019

AT Publication Date

15.05.2019

Application Date

14.05.2012

Registration Number

Priorities

12.05.2011

201161485179 P

IPC

A61K 31/65 20060101AFI20141007BHEP

Maximum Duration of Protection

14.05.2032

Owner

Paratek Pharmaceuticals, Inc.75 Park Plaza Boston, MA 02116US

Allergan Pharmaceuticals International LimitedClonshaugh Industrial Estate Coolock Dublin 17IE

Representative

Barger Werner Dipl.Ing., Israiloff Peter Dipl.Ing. Dr.techn.Operngasse 41010 WienAT

Inventor

COULTER, Catherine38 Church Road Gracehill Ballymena Co AntrimIE

JOHNSTON, Sean, M.4360 Wismer Road Doylestown PA 18902US

SEYEDI, Farzaneh43 Ridgeview Lane Mansfield MA 02048US